Stock Price Quote

DR AGARWALS EYE HOSPITAL LTD.

NSE : NABSE : 526783ISIN CODE : INE934C01018Industry : Hospital & Healthcare ServicesHouse : Private
BSE6875.1069.15 (+1.02 %)
PREV CLOSE ( ) 6805.95
OPEN PRICE ( ) 6800.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2206
TODAY'S LOW / HIGH ( )6750.00 6880.00
52 WK LOW / HIGH ( ) 2541.87300
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 22-04 1994
Management Info
Amar Agarwal - Chairman Amar Agarwal - Managing Director
Registered Office

Address 3rd Floor, Buhari Towers, No.4, Moores Road,Off. Greams Road,Near Asan Memorial School,
Chennai,
Tamil Nadu-600006

Phone 044-43787777 / 78

Email info@dragarwal.com

Website www.dragarwal.com

Registrars Details
Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai
Listing : BSE

NEWS

29Oct Appointment of Director
Inter alia, approved:- 1. Declaration of interim dividend of INR 2.5..
29Oct Notice of Postal Ballot
Inter alia, approved:- 1. Declaration of interim dividend of INR 2.5..
30Sep Dr. Agarwal’s Eye Hospital informs abo
As per the SEBI (Prohibition of Insider Trading) Regulations, 2015 and t..
28Sep Dr.Agarwals Eye Hospital informs about
Dr.Agarwals Eye Hospital has informed that the Exchange has received Dis..
23Sep Dr. Agarwal’s Eye Hospital informs abo
Pursuant to Regulation 30 read with Para B of Part A of Schedule III of..

Financials

in Millions
QTR Sep 24 ANNUAL 24
Net Profit141.5463.6
Gross Profit 191.3 622.5
Operating Profit 321.6960.3
Net Sales 1021.93193

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Jupiter Life Line (BSE)
peergroup  1590.00 (2.63%)
M.Cap ( in Cr)10372.22
Global Health (BSE)
peergroup  1079.00 (1.49%)
M.Cap ( in Cr)28887.92
Narayana Hrudayalay (BSE)
peergroup  1365.30 (1.06%)
M.Cap ( in Cr)27833.94
Krishna Inst.Medi (BSE)
peergroup  661.60 (1.96%)
M.Cap ( in Cr)26427.18
Aspira Pathlab&Diagn (BSE)
peergroup  70.87 (4.99%)
M.Cap ( in Cr)72.95

Shareholding Pattern

PROMOTERS 71.9%
NON-INSTITUTION 26.31%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Dr Agarwals Eye Hospital Ltd.

Dr Agarwals Eye Hospital Ltd. was incorporated in the year 1994. Its today's share price is 6875.1. Its current market capitalisation stands at Rs 3214.8 Cr. In the latest quarter, company has reported Gross Sales of Rs. 3193 Cr and Total Income of Rs.3244.8 Cr. The company's management includes Meenakshi Jayaraman, Latha Ramanathan, Balakrishnan Venkatraman, Adil Agarwal, Athiya Agarwal, Amar Agarwal, Amar Agarwal.

It is listed on the BSE with a BSE Code of 526783 , NSE with an NSE Symbol of and ISIN of INE934C01018. It's Registered office is at 3rd Floor, Buhari Towers, No.4, Moores Road,Off. Greams Road,Near Asan Memorial SchoolChennai-600006, Tamil Nadu. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Deloitte Haskins & Sells, MK Dandekar & Co, MK Dandeker & Co

1.NSE exchange is Stopping the facility of Stop-Loss Market (SL-M) orders In option trade from 27th Sept 2021 to avoid freak trades and reduce its impact significantly. 2. Introduction of T+1 rolling settlement on optional basis. Stock Exchange may choose to offer T+1 settlement cycle. There shall be no netting between T+1 and T+2 settlements. Circular provisions come into force with effect from Jan: @SEBI_India 3. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. 4. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 5. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Do not share sensitive information like User ID, Password, OTP, etc., with anyone. Regards, Nirmal Bang.
1.NSE exchange is Stopping the facility of Stop-Loss Market (SL-M) orders In option trade from 27th Sept 2021 to avoid freak trades and reduce its impact significantly. 2. Introduction of T+1 rolling settlement on optional basis. Stock Exchange may choose to offer T+1 settlement cycle. There shall be no netting between T+1 and T+2 settlements. Circular provisions come into force with effect from Jan: @SEBI_India 3. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. 4. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 5. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Do not share sensitive information like User ID, Password, OTP, etc., with anyone. Regards, Nirmal Bang.

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.
Close X
OPEN

DEMAT ACCOUNT

AND START YOUR

INVESTMENT

JOURNEY WITH US
(You will receive a Call & SMS from our end)
Popup-Character

Disclaimer: NIRMAL BANG SECURITIES PVT LTD: Investment in Securities market are subject to market risks. Read all the related documents carefully before investing. Please read the Do’s and Don’ts prescribed by the Commodity Exchange before trading. We do not offer PMS Service for the Commodity segment. Opening of account will not guarantee allotment of shares in IPO. Investors are requested to do their own due diligence before investing in any IPO. The securities quoted are exemplary and are not recommendatory. BSE (Member ID- 498): INB011072759, INF011072759, Exchange Registered Member in CDS; NSE MEMEBR ID- 09391): INB230939139, INF230939139, INE230939139; MSEI Member ID-1067): INB260939138, INF260939138, INE260939139: Single Registration No. INZ000202536, PMS Registration No: INP000002981; Research Analyst Registration No: INH000001766; NSDL/ CDSL: IN-DP-CDSL 37-99; Exchange Member ID: MCX - 56460, NCDEX - 1268, ICEX – 2073. Regd. Office: B-2, 301/302, 3rd Floor, Marathon Innova, Off Ganpatrao Kadam Marg, Lower Parel (W), Mumbai - 400013. Tel: 62738000/01; Fax: 62738010 | *NIRMAL BANG NIVESHALAYA PVT LTD: ARN – 111233, Mutual Fund Distributor. Mutual Fund Investments are subject to market risks. Please read the offer documents carefully before Investing.” Regd. Office: B - 201, Khandelwal House, Poddar Road, Near Poddar Park, Malad (East). Mumbai – 400097. | **NIRMAL BANG INSURANCE BROKING PVT LTD: IRDAI Registration No: 795 and Registration Code For the Insurance Broker: IRDAI/DB889/2021. Insurance is the subject matter of the solicitation. For more details on policy terms, conditions, exclusions, limitations, please refer/read policy brochure carefully before concluding sale.